Quidel | QDEL - Assets


Quidel reported $5.77B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Agilent USD 12.73B 501M Sep/2025
Avanos Medical USD 1.07B 6M Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Bruker USD 6.24B 193.5M Dec/2025
Cerus USD 215.18M 2.11M Sep/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Danaher USD 83.46B 3.57B Dec/2025
Exact Sciences USD 5.86B 39.38M Dec/2025
Haemonetics USD 2.49B 48.73M Dec/2025
Hologic USD 9.18B 165.8M Dec/2025
Illumina USD 6.64B 467M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Merit Medical Systems USD 2.63B 44.95M Sep/2025
Mettler Toledo International USD 3.71B 191.18M Dec/2025
Myriad Genetics USD 728.1M 50.8M Sep/2025
Neogen USD 3.36B 18.21M Sep/2025
OraSure Technologies USD 423.1M 21.94M Sep/2025
Pacific Biosciences Of California USD 803.16M 22.31M Sep/2025
Quidel USD 5.77B 94.2M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
STAAR Surgical USD 456.36M 18.58M Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Waters USD 5.08B 221.41M Dec/2025